SAN CARLOS, Calif., Sept. 24, 2019 /PRNewswire/ — Empirical Spine, Inc., a Silicon-Valley based medical technology company, announced today that data from the IDE study of the company’s LimiFlex Paraspinous Tension Band for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis, will be presented at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum 2019. The SMISS Annual Forum takes place from October 31 – November 2, 2019 in Las Vegas, Nevada.
On Friday, November 1, Dr. Hyun Bae, LimiFlex Principal Investigator at the Spine Institute in Santa Monica, CA, will present preliminary safety and outcomes data from 100 subjects with 6 month follow-up.
About LimiFlex 
The LimiFlex Paraspinous Tension Band is a new, investigational device designed as an alternative to spinal fusion for patients receiving surgical decompression for grade 1 lumbar degenerative spondylolisthesis with spinal stenosis. LimiFlex does not involve any screws or bone grafts, which eliminate the natural motion between spine segments. Instead, LimiFlex is designed to stabilize the spine without fusing it, thereby preserving motion. The device works by supporting and enhancing the spine’s natural biomechanics with stabilizing yet flexible elements. The LimiFlex device is placed following a standard decompression surgery, typically in less than 30 minutes.
About Empirical Spine
Empirical Spine, Inc., founded in 2015, is a privately held company developing advanced solutions for the surgical treatment of spinal disorders. The company is currently running a pivotal IDE trial in the US on its breakthrough, motion-preserving Paraspinous Tension Band, LimiFlex. LimiFlex is a minimally invasive implant that stabilizes the spine after decompression surgery yet preserves motion.
Caution: The LimiFlex Paraspinous Tension Band is an investigational device in the United States and is limited by law to investigational use.
SOURCE Empirical Spine